💊 यो जानकारी मात्र हो, प्रिस्क्रिप्सन होइन। कुनै पनि औषधि लिनुअघि डाक्टर वा फार्मासिस्टसँग सल्लाह लिनुहोस्। ओभरडोज वा विषाक्तता भए १०२ मा फोन गर्नुहोस्।
Commonly Observed The most commonly observed adverse events associated with the use of clomipramine hydrochloride capsules, USP and not seen at an equivalent incidence among placebo-treated patients were gastrointestinal complaints, including dry mouth, constipation, nausea, dyspepsia, and anorexia; nervous system complaints, including somnolence,... Pregnancy (label summary): There are no adequate or well-controlled studies in pregnant women. Withdrawal symptoms, including jitteriness, tremor, and seizures, have been reported in neonates whose mothers had taken clomipramine hydrochloride capsules, USP until delivery. Breastfeeding (label summary): Nursing Mothers Clomipramine hydrochloride capsules, USP have been found in human milk. General information only, not medical advice and not a prescription. No doses are given. Always consult a doctor or pharmacist before starting, stopping or changing any medicine, especially in pregnancy, breastfeeding, children, older age or with other medicines.
स्रोत: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference
US FDA DailyMed; NLM RxNorm